Archived Events
Archived Events
-
Dec 2, 2020 at 1:30 PM EST Piper Sandler 32nd Annual Virtual Healthcare Conference
-
Dec 2, 2020 at 9:15 AM EST 2020 Evercore ISI HealthCONx Conference
-
Nov 17, 2020 at 5:35 PM GMT Jefferies Virtual London Healthcare Conference
-
Nov 17, 2020 at 10:40 AM EST Stifel 2020 Virtual Healthcare Conference
-
Nov 2, 2020 at 8:00 AM EST Horizon Therapeutics Third Quarter 2020 Earnings Call
Supporting Materials
Q3 2020 Earnings Release 400.8 KBQ3 2020 Presentation 4.2 MBQ3 2020 Conference Call Remarks 265.4 KB -
Sep 16, 2020 at 12:30 PM EDT Morgan Stanley 18th Annual Global Healthcare Conference (Virtual)
-
Aug 5, 2020 at 8:00 AM EDT Horizon Therapeutics Second Quarter 2020 Earnings Call
Supporting Materials
Q2 2020 Earnings Release 406.8 KBQ2 2020 Presentation 1.5 MBQ2 2020 Conference Call Remarks 228.4 KB -
Jul 31, 2020 at 9:00 AM EDT New TEPEZZA OPTIC-X and OPTIC Trial Data
-
Jun 23, 2020 at 10:30 AM EDT BMO 2020 Prescriptions for Success Healthcare Conference (Virtual)
-
Jun 4, 2020 at 3:00 PM EDT KRYSTEXXA Immunomodulation Strategy and EULAR Data
Supporting Materials
-
Jun 2, 2020 at 1:00 PM EDT Jefferies 2020 Virtual Healthcare Conference
-
May 6, 2020 at 8:00 AM EDT Horizon Therapeutics First Quarter 2020 Earnings Call
Supporting Materials
Q1 2020 Earnings Release 384.3 KBQ1 2020 Presentation 1.6 MBQ1 2020 Conference Call Remarks 139.4 KB -
Apr 2, 2020 at 8:00 AM EDT Horizon Acquisition of Curzion (4/2/20)
-
Mar 3, 2020 at 12:00 PM EST Cowen and Company 40th Annual Health Care Conference
-
Feb 26, 2020 at 8:00 AM EST Horizon Therapeutics Fourth Quarter 2019 Earnings Call
Supporting Materials
Q4 2019 Earnings Release 345.4 KBQ4 2019 Presentation 4.6 MBQ4 2019 Conference Call Remarks 167.7 KB -
Jan 21, 2020 at 5:00 PM EST FDA Approval of Teprotumumab/TEPEZZA™
Supporting Materials
View Presentation 1.6 MB -
Jan 15, 2020 at 5:00 PM PST 38th Annual J.P. Morgan Healthcare Conference - Presentation
-
Apr 29, 2019 Dr. R. Douglas’s AACE IR TED/OPTIC Presentation
-
Feb 28, 2019 at 8:00 AM EST Overview of Teprotumumab OPTIC Phase 3 Trial Topline Results and Thyroid Eye Disease (TED)
Supporting Materials
-
Oct 4, 2018 at 10:30 AM EDT Overview of Thyroid Eye Disease (TED) and Teprotumumab Clinical Data
Supporting Materials
-
Nov 9, 2017 at 10:00 AM EST KRYSTEXXA ACR Investor Webcast & Presentation
Supporting Materials